| Dataset | w6a_vs_wt_vs_wt.w6a_vs_wt.cls #ago1w6a_versus_ago1gfp.w6a_vs_wt.cls #ago1w6a_versus_ago1gfp_repos |
| Phenotype | w6a_vs_wt.cls#ago1w6a_versus_ago1gfp_repos |
| Upregulated in class | ago1w6a |
| GeneSet | HALLMARK_TNFA_SIGNALING_VIA_NFKB |
| Enrichment Score (ES) | 0.63695526 |
| Normalized Enrichment Score (NES) | 2.731225 |
| Nominal p-value | 0.0 |
| FDR q-value | 0.0 |
| FWER p-Value | 0.0 |

| PROBE | DESCRIPTION (from dataset) | GENE SYMBOL | GENE_TITLE | RANK IN GENE LIST | RANK METRIC SCORE | RUNNING ES | CORE ENRICHMENT | |
|---|---|---|---|---|---|---|---|---|
| 1 | CXCL11 | NA | CXCL11 Entrez,  Source | chemokine (C-X-C motif) ligand 11 | 1 | 4.764 | 0.0224 | Yes |
| 2 | IL7R | NA | IL7R Entrez,  Source | interleukin 7 receptor | 3 | 4.680 | 0.0445 | Yes |
| 3 | CCL5 | NA | CCL5 Entrez,  Source | chemokine (C-C motif) ligand 5 | 10 | 4.462 | 0.0652 | Yes |
| 4 | DDX58 | NA | DDX58 Entrez,  Source | DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 | 13 | 4.397 | 0.0858 | Yes |
| 5 | IL6 | NA | IL6 Entrez,  Source | interleukin 6 (interferon, beta 2) | 15 | 4.383 | 0.1064 | Yes |
| 6 | CXCL10 | NA | CXCL10 Entrez,  Source | chemokine (C-X-C motif) ligand 10 | 16 | 4.314 | 0.1268 | Yes |
| 7 | IFIT2 | NA | IFIT2 Entrez,  Source | interferon-induced protein with tetratricopeptide repeats 2 | 24 | 4.140 | 0.1459 | Yes |
| 8 | CYR61 | NA | CYR61 Entrez,  Source | cysteine-rich, angiogenic inducer, 61 | 53 | 3.446 | 0.1601 | Yes |
| 9 | IFIH1 | NA | IFIH1 Entrez,  Source | interferon induced with helicase C domain 1 | 60 | 3.343 | 0.1755 | Yes |
| 10 | FOSL1 | NA | FOSL1 Entrez,  Source | FOS-like antigen 1 | 67 | 3.260 | 0.1905 | Yes |
| 11 | TRAF1 | NA | TRAF1 Entrez,  Source | TNF receptor-associated factor 1 | 88 | 3.029 | 0.2033 | Yes |
| 12 | CCL2 | NA | CCL2 Entrez,  Source | chemokine (C-C motif) ligand 2 | 98 | 2.964 | 0.2167 | Yes |
| 13 | SERPINE1 | NA | SERPINE1 Entrez,  Source | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 109 | 2.840 | 0.2294 | Yes |
| 14 | TNFAIP3 | NA | TNFAIP3 Entrez,  Source | tumor necrosis factor, alpha-induced protein 3 | 112 | 2.804 | 0.2425 | Yes |
| 15 | AREG | NA | AREG Entrez,  Source | amphiregulin (schwannoma-derived growth factor) | 113 | 2.770 | 0.2556 | Yes |
| 16 | RELB | NA | RELB Entrez,  Source | v-rel reticuloendotheliosis viral oncogene homolog B, nuclear factor of kappa light polypeptide gene enhancer in B-cells 3 (avian) | 116 | 2.710 | 0.2682 | Yes |
| 17 | SDC4 | NA | SDC4 Entrez,  Source | syndecan 4 (amphiglycan, ryudocan) | 149 | 2.503 | 0.2777 | Yes |
| 18 | BIRC3 | NA | BIRC3 Entrez,  Source | baculoviral IAP repeat-containing 3 | 152 | 2.495 | 0.2894 | Yes |
| 19 | PTGER4 | NA | PTGER4 Entrez,  Source | prostaglandin E receptor 4 (subtype EP4) | 159 | 2.450 | 0.3005 | Yes |
| 20 | GADD45A | NA | GADD45A Entrez,  Source | growth arrest and DNA-damage-inducible, alpha | 161 | 2.429 | 0.3119 | Yes |
| 21 | CXCL2 | NA | CXCL2 Entrez,  Source | chemokine (C-X-C motif) ligand 2 | 162 | 2.420 | 0.3234 | Yes |
| 22 | NFKB2 | NA | NFKB2 Entrez,  Source | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | 172 | 2.369 | 0.3339 | Yes |
| 23 | F3 | NA | F3 Entrez,  Source | coagulation factor III (thromboplastin, tissue factor) | 184 | 2.322 | 0.3441 | Yes |
| 24 | PLAUR | NA | PLAUR Entrez,  Source | plasminogen activator, urokinase receptor | 187 | 2.308 | 0.3549 | Yes |
| 25 | F2RL1 | NA | F2RL1 Entrez,  Source | coagulation factor II (thrombin) receptor-like 1 | 190 | 2.275 | 0.3655 | Yes |
| 26 | PHLDA1 | NA | PHLDA1 Entrez,  Source | pleckstrin homology-like domain, family A, member 1 | 194 | 2.257 | 0.3759 | Yes |
| 27 | FJX1 | NA | FJX1 Entrez,  Source | four jointed box 1 (Drosophila) | 205 | 2.189 | 0.3855 | Yes |
| 28 | OLR1 | NA | OLR1 Entrez,  Source | oxidised low density lipoprotein (lectin-like) receptor 1 | 209 | 2.171 | 0.3956 | Yes |
| 29 | JUN | NA | JUN Entrez,  Source | jun oncogene | 236 | 1.996 | 0.4031 | Yes |
| 30 | ICAM1 | NA | ICAM1 Entrez,  Source | intercellular adhesion molecule 1 (CD54), human rhinovirus receptor | 251 | 1.952 | 0.4113 | Yes |
| 31 | IRF1 | NA | IRF1 Entrez,  Source | interferon regulatory factor 1 | 252 | 1.947 | 0.4205 | Yes |
| 32 | MXD1 | NA | MXD1 Entrez,  Source | MAX dimerization protein 1 | 256 | 1.938 | 0.4295 | Yes |
| 33 | EDN1 | NA | EDN1 Entrez,  Source | endothelin 1 | 278 | 1.829 | 0.4366 | Yes |
| 34 | DUSP5 | NA | DUSP5 Entrez,  Source | dual specificity phosphatase 5 | 280 | 1.814 | 0.4451 | Yes |
| 35 | PPP1R15A | NA | PPP1R15A Entrez,  Source | protein phosphatase 1, regulatory (inhibitor) subunit 15A | 286 | 1.797 | 0.4532 | Yes |
| 36 | TNIP1 | NA | TNIP1 Entrez,  Source | TNFAIP3 interacting protein 1 | 295 | 1.780 | 0.4610 | Yes |
| 37 | CLCF1 | NA | CLCF1 Entrez,  Source | cardiotrophin-like cytokine factor 1 | 309 | 1.735 | 0.4683 | Yes |
| 38 | HBEGF | NA | HBEGF Entrez,  Source | heparin-binding EGF-like growth factor | 319 | 1.713 | 0.4757 | Yes |
| 39 | CD44 | NA | CD44 Entrez,  Source | CD44 molecule (Indian blood group) | 336 | 1.659 | 0.4824 | Yes |
| 40 | NFKBIE | NA | NFKBIE Entrez,  Source | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | 340 | 1.648 | 0.4900 | Yes |
| 41 | IL12B | NA | IL12B Entrez,  Source | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) | 366 | 1.567 | 0.4955 | Yes |
| 42 | PANX1 | NA | PANX1 Entrez,  Source | pannexin 1 | 382 | 1.531 | 0.5017 | Yes |
| 43 | SOCS3 | NA | SOCS3 Entrez,  Source | suppressor of cytokine signaling 3 | 384 | 1.526 | 0.5088 | Yes |
| 44 | PDE4B | NA | PDE4B Entrez,  Source | phosphodiesterase 4B, cAMP-specific (phosphodiesterase E4 dunce homolog, Drosophila) | 388 | 1.523 | 0.5158 | Yes |
| 45 | TUBB2A | NA | TUBB2A Entrez,  Source | tubulin, beta 2A | 389 | 1.523 | 0.5230 | Yes |
| 46 | SERPINB8 | NA | SERPINB8 Entrez,  Source | serpin peptidase inhibitor, clade B (ovalbumin), member 8 | 402 | 1.502 | 0.5292 | Yes |
| 47 | JAG1 | NA | JAG1 Entrez,  Source | jagged 1 (Alagille syndrome) | 432 | 1.447 | 0.5339 | Yes |
| 48 | B4GALT5 | NA | B4GALT5 Entrez,  Source | UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5 | 453 | 1.405 | 0.5391 | Yes |
| 49 | IER5 | NA | IER5 Entrez,  Source | immediate early response 5 | 506 | 1.300 | 0.5415 | Yes |
| 50 | RNF19B | NA | 507 | 1.300 | 0.5476 | Yes | ||
| 51 | FUT4 | NA | FUT4 Entrez,  Source | fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific) | 559 | 1.237 | 0.5497 | Yes |
| 52 | KLF4 | NA | KLF4 Entrez,  Source | Kruppel-like factor 4 (gut) | 566 | 1.222 | 0.5551 | Yes |
| 53 | MAP2K3 | NA | MAP2K3 Entrez,  Source | mitogen-activated protein kinase kinase 3 | 572 | 1.213 | 0.5604 | Yes |
| 54 | IL6ST | NA | IL6ST Entrez,  Source | interleukin 6 signal transducer (gp130, oncostatin M receptor) | 645 | 1.142 | 0.5606 | Yes |
| 55 | ZFP36 | NA | ZFP36 Entrez,  Source | zinc finger protein 36, C3H type, homolog (mouse) | 646 | 1.140 | 0.5659 | Yes |
| 56 | TIPARP | NA | TIPARP Entrez,  Source | TCDD-inducible poly(ADP-ribose) polymerase | 649 | 1.138 | 0.5712 | Yes |
| 57 | MCL1 | NA | MCL1 Entrez,  Source | myeloid cell leukemia sequence 1 (BCL2-related) | 684 | 1.113 | 0.5740 | Yes |
| 58 | TAP1 | NA | TAP1 Entrez,  Source | transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) | 686 | 1.112 | 0.5791 | Yes |
| 59 | NFAT5 | NA | NFAT5 Entrez,  Source | nuclear factor of activated T-cells 5, tonicity-responsive | 724 | 1.072 | 0.5815 | Yes |
| 60 | LIF | NA | LIF Entrez,  Source | leukemia inhibitory factor (cholinergic differentiation factor) | 745 | 1.056 | 0.5850 | Yes |
| 61 | HES1 | NA | HES1 Entrez,  Source | hairy and enhancer of split 1, (Drosophila) | 764 | 1.038 | 0.5886 | Yes |
| 62 | TNIP2 | NA | TNIP2 Entrez,  Source | TNFAIP3 interacting protein 2 | 777 | 1.033 | 0.5926 | Yes |
| 63 | PLK2 | NA | PLK2 Entrez,  Source | polo-like kinase 2 (Drosophila) | 778 | 1.033 | 0.5975 | Yes |
| 64 | LDLR | NA | LDLR Entrez,  Source | low density lipoprotein receptor (familial hypercholesterolemia) | 803 | 1.007 | 0.6005 | Yes |
| 65 | IL18 | NA | IL18 Entrez,  Source | interleukin 18 (interferon-gamma-inducing factor) | 831 | 0.988 | 0.6032 | Yes |
| 66 | YRDC | NA | YRDC Entrez,  Source | yrdC domain containing (E. coli) | 890 | 0.949 | 0.6034 | Yes |
| 67 | SOD2 | NA | SOD2 Entrez,  Source | superoxide dismutase 2, mitochondrial | 897 | 0.945 | 0.6075 | Yes |
| 68 | PTGS2 | NA | PTGS2 Entrez,  Source | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 902 | 0.945 | 0.6116 | Yes |
| 69 | IL1A | NA | IL1A Entrez,  Source | interleukin 1, alpha | 977 | 0.904 | 0.6105 | Yes |
| 70 | MAFF | NA | MAFF Entrez,  Source | v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) | 1023 | 0.882 | 0.6114 | Yes |
| 71 | SMAD3 | NA | SMAD3 Entrez,  Source | SMAD, mothers against DPP homolog 3 (Drosophila) | 1025 | 0.881 | 0.6155 | Yes |
| 72 | CCND1 | NA | CCND1 Entrez,  Source | cyclin D1 | 1033 | 0.877 | 0.6191 | Yes |
| 73 | PHLDA2 | NA | PHLDA2 Entrez,  Source | pleckstrin homology-like domain, family A, member 2 | 1091 | 0.854 | 0.6190 | Yes |
| 74 | SQSTM1 | NA | SQSTM1 Entrez,  Source | sequestosome 1 | 1130 | 0.838 | 0.6201 | Yes |
| 75 | DRAM1 | NA | 1136 | 0.836 | 0.6237 | Yes | ||
| 76 | KLF10 | NA | KLF10 Entrez,  Source | Kruppel-like factor 10 | 1141 | 0.835 | 0.6274 | Yes |
| 77 | SPHK1 | NA | SPHK1 Entrez,  Source | sphingosine kinase 1 | 1198 | 0.814 | 0.6271 | Yes |
| 78 | STAT5A | NA | STAT5A Entrez,  Source | signal transducer and activator of transcription 5A | 1238 | 0.797 | 0.6280 | Yes |
| 79 | FOSB | NA | FOSB Entrez,  Source | FBJ murine osteosarcoma viral oncogene homolog B | 1266 | 0.789 | 0.6298 | Yes |
| 80 | PDLIM5 | NA | PDLIM5 Entrez,  Source | PDZ and LIM domain 5 | 1269 | 0.789 | 0.6334 | Yes |
| 81 | IER3 | NA | IER3 Entrez,  Source | immediate early response 3 | 1272 | 0.788 | 0.6370 | Yes |
| 82 | EHD1 | NA | EHD1 Entrez,  Source | EH-domain containing 1 | 1357 | 0.753 | 0.6344 | No |
| 83 | CCRL2 | NA | CCRL2 Entrez,  Source | chemokine (C-C motif) receptor-like 2 | 1408 | 0.741 | 0.6342 | No |
| 84 | NAMPT | NA | 1439 | 0.734 | 0.6355 | No | ||
| 85 | NFKBIA | NA | NFKBIA Entrez,  Source | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 1484 | 0.721 | 0.6357 | No |
| 86 | RELA | NA | RELA Entrez,  Source | v-rel reticuloendotheliosis viral oncogene homolog A, nuclear factor of kappa light polypeptide gene enhancer in B-cells 3, p65 (avian) | 1570 | 0.698 | 0.6327 | No |
| 87 | IL15RA | NA | IL15RA Entrez,  Source | interleukin 15 receptor, alpha | 1690 | 0.661 | 0.6272 | No |
| 88 | RCAN1 | NA | 1789 | 0.636 | 0.6230 | No | ||
| 89 | BIRC2 | NA | BIRC2 Entrez,  Source | baculoviral IAP repeat-containing 2 | 1964 | 0.594 | 0.6131 | No |
| 90 | NFKB1 | NA | NFKB1 Entrez,  Source | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105) | 2004 | 0.585 | 0.6130 | No |
| 91 | ATP2B1 | NA | ATP2B1 Entrez,  Source | ATPase, Ca++ transporting, plasma membrane 1 | 2127 | 0.565 | 0.6067 | No |
| 92 | PFKFB3 | NA | PFKFB3 Entrez,  Source | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 | 2141 | 0.563 | 0.6084 | No |
| 93 | CEBPB | NA | CEBPB Entrez,  Source | CCAAT/enhancer binding protein (C/EBP), beta | 2220 | 0.547 | 0.6053 | No |
| 94 | EIF1 | NA | EIF1 Entrez,  Source | eukaryotic translation initiation factor 1 | 2249 | 0.542 | 0.6058 | No |
| 95 | TGIF1 | NA | 2299 | 0.534 | 0.6047 | No | ||
| 96 | BCL3 | NA | BCL3 Entrez,  Source | B-cell CLL/lymphoma 3 | 2421 | 0.512 | 0.5983 | No |
| 97 | FOSL2 | NA | FOSL2 Entrez,  Source | FOS-like antigen 2 | 2524 | 0.497 | 0.5932 | No |
| 98 | IL1B | NA | IL1B Entrez,  Source | interleukin 1, beta | 2581 | 0.487 | 0.5914 | No |
| 99 | IL23A | NA | IL23A Entrez,  Source | interleukin 23, alpha subunit p19 | 2610 | 0.483 | 0.5916 | No |
| 100 | CXCL3 | NA | CXCL3 Entrez,  Source | chemokine (C-X-C motif) ligand 3 | 2875 | 0.438 | 0.5743 | No |
| 101 | SAT1 | NA | SAT1 Entrez,  Source | spermidine/spermine N1-acetyltransferase 1 | 2943 | 0.428 | 0.5715 | No |
| 102 | IER2 | NA | IER2 Entrez,  Source | immediate early response 2 | 3041 | 0.416 | 0.5663 | No |
| 103 | KDM6B | NA | 3230 | 0.390 | 0.5544 | No | ||
| 104 | NR4A1 | NA | NR4A1 Entrez,  Source | nuclear receptor subfamily 4, group A, member 1 | 3436 | 0.362 | 0.5411 | No |
| 105 | TRIP10 | NA | TRIP10 Entrez,  Source | thyroid hormone receptor interactor 10 | 4029 | 0.294 | 0.4992 | No |
| 106 | TNC | NA | TNC Entrez,  Source | tenascin C (hexabrachion) | 4457 | 0.248 | 0.4691 | No |
| 107 | GADD45B | NA | GADD45B Entrez,  Source | growth arrest and DNA-damage-inducible, beta | 4506 | 0.242 | 0.4667 | No |
| 108 | SPSB1 | NA | SPSB1 Entrez,  Source | splA/ryanodine receptor domain and SOCS box containing 1 | 4582 | 0.234 | 0.4623 | No |
| 109 | RIPK2 | NA | RIPK2 Entrez,  Source | receptor-interacting serine-threonine kinase 2 | 4588 | 0.233 | 0.4630 | No |
| 110 | TRIB1 | NA | TRIB1 Entrez,  Source | tribbles homolog 1 (Drosophila) | 4679 | 0.225 | 0.4575 | No |
| 111 | KLF6 | NA | KLF6 Entrez,  Source | Kruppel-like factor 6 | 4776 | 0.214 | 0.4515 | No |
| 112 | TANK | NA | TANK Entrez,  Source | TRAF family member-associated NFKB activator | 4790 | 0.213 | 0.4516 | No |
| 113 | TNFRSF9 | NA | TNFRSF9 Entrez,  Source | tumor necrosis factor receptor superfamily, member 9 | 5250 | 0.166 | 0.4187 | No |
| 114 | CCNL1 | NA | CCNL1 Entrez,  Source | cyclin L1 | 5272 | 0.164 | 0.4180 | No |
| 115 | GCH1 | NA | GCH1 Entrez,  Source | GTP cyclohydrolase 1 (dopa-responsive dystonia) | 5304 | 0.161 | 0.4165 | No |
| 116 | JUNB | NA | JUNB Entrez,  Source | jun B proto-oncogene | 5457 | 0.145 | 0.4060 | No |
| 117 | DNAJB4 | NA | DNAJB4 Entrez,  Source | DnaJ (Hsp40) homolog, subfamily B, member 4 | 5479 | 0.142 | 0.4052 | No |
| 118 | CDKN1A | NA | CDKN1A Entrez,  Source | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 5707 | 0.115 | 0.3891 | No |
| 119 | EGR1 | NA | EGR1 Entrez,  Source | early growth response 1 | 5919 | 0.095 | 0.3741 | No |
| 120 | BHLHE40 | NA | 6073 | 0.080 | 0.3633 | No | ||
| 121 | NFE2L2 | NA | NFE2L2 Entrez,  Source | nuclear factor (erythroid-derived 2)-like 2 | 6087 | 0.079 | 0.3627 | No |
| 122 | LAMB3 | NA | LAMB3 Entrez,  Source | laminin, beta 3 | 6357 | 0.054 | 0.3432 | No |
| 123 | CFLAR | NA | CFLAR Entrez,  Source | CASP8 and FADD-like apoptosis regulator | 6359 | 0.053 | 0.3434 | No |
| 124 | ZC3H12A | NA | ZC3H12A Entrez,  Source | zinc finger CCCH-type containing 12A | 6598 | 0.028 | 0.3261 | No |
| 125 | REL | NA | REL Entrez,  Source | v-rel reticuloendotheliosis viral oncogene homolog (avian) | 6603 | 0.028 | 0.3260 | No |
| 126 | MAP3K8 | NA | MAP3K8 Entrez,  Source | mitogen-activated protein kinase kinase kinase 8 | 6608 | 0.027 | 0.3258 | No |
| 127 | DUSP1 | NA | DUSP1 Entrez,  Source | dual specificity phosphatase 1 | 6982 | -0.013 | 0.2986 | No |
| 128 | VEGFA | NA | 7811 | -0.096 | 0.2384 | No | ||
| 129 | MARCKS | NA | MARCKS Entrez,  Source | myristoylated alanine-rich protein kinase C substrate | 7910 | -0.105 | 0.2317 | No |
| 130 | PLEK | NA | PLEK Entrez,  Source | pleckstrin | 8123 | -0.128 | 0.2168 | No |
| 131 | BTG1 | NA | BTG1 Entrez,  Source | B-cell translocation gene 1, anti-proliferative | 8251 | -0.143 | 0.2082 | No |
| 132 | GFPT2 | NA | GFPT2 Entrez,  Source | glutamine-fructose-6-phosphate transaminase 2 | 8574 | -0.177 | 0.1854 | No |
| 133 | BTG3 | NA | BTG3 Entrez,  Source | BTG family, member 3 | 8698 | -0.191 | 0.1773 | No |
| 134 | ICOSLG | NA | ICOSLG Entrez,  Source | inducible T-cell co-stimulator ligand | 8708 | -0.192 | 0.1776 | No |
| 135 | ETS2 | NA | ETS2 Entrez,  Source | v-ets erythroblastosis virus E26 oncogene homolog 2 (avian) | 8936 | -0.218 | 0.1620 | No |
| 136 | TNFAIP8 | NA | TNFAIP8 Entrez,  Source | tumor necrosis factor, alpha-induced protein 8 | 9099 | -0.237 | 0.1512 | No |
| 137 | TNFAIP2 | NA | TNFAIP2 Entrez,  Source | tumor necrosis factor, alpha-induced protein 2 | 9418 | -0.282 | 0.1293 | No |
| 138 | IFNGR2 | NA | IFNGR2 Entrez,  Source | interferon gamma receptor 2 (interferon gamma transducer 1) | 9538 | -0.299 | 0.1220 | No |
| 139 | TSC22D1 | NA | TSC22D1 Entrez,  Source | TSC22 domain family, member 1 | 9700 | -0.321 | 0.1117 | No |
| 140 | MYC | NA | MYC Entrez,  Source | v-myc myelocytomatosis viral oncogene homolog (avian) | 9860 | -0.346 | 0.1017 | No |
| 141 | SNN | NA | SNN Entrez,  Source | stannin | 9889 | -0.349 | 0.1013 | No |
| 142 | BCL6 | NA | BCL6 Entrez,  Source | B-cell CLL/lymphoma 6 (zinc finger protein 51) | 9958 | -0.358 | 0.0980 | No |
| 143 | PER1 | NA | PER1 Entrez,  Source | period homolog 1 (Drosophila) | 10119 | -0.381 | 0.0881 | No |
| 144 | LITAF | NA | LITAF Entrez,  Source | lipopolysaccharide-induced TNF factor | 10242 | -0.401 | 0.0811 | No |
| 145 | PTPRE | NA | PTPRE Entrez,  Source | protein tyrosine phosphatase, receptor type, E | 10421 | -0.430 | 0.0701 | No |
| 146 | TNFSF9 | NA | TNFSF9 Entrez,  Source | tumor necrosis factor (ligand) superfamily, member 9 | 10580 | -0.455 | 0.0607 | No |
| 147 | NINJ1 | NA | NINJ1 Entrez,  Source | ninjurin 1 | 11112 | -0.548 | 0.0244 | No |
| 148 | DENND5A | NA | 11166 | -0.557 | 0.0231 | No | ||
| 149 | CEBPD | NA | CEBPD Entrez,  Source | CCAAT/enhancer binding protein (C/EBP), delta | 11371 | -0.598 | 0.0110 | No |
| 150 | DUSP4 | NA | DUSP4 Entrez,  Source | dual specificity phosphatase 4 | 11499 | -0.623 | 0.0047 | No |
| 151 | EFNA1 | NA | EFNA1 Entrez,  Source | ephrin-A1 | 11525 | -0.629 | 0.0058 | No |
| 152 | B4GALT1 | NA | B4GALT1 Entrez,  Source | UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 | 11626 | -0.655 | 0.0016 | No |
| 153 | KYNU | NA | KYNU Entrez,  Source | kynureninase (L-kynurenine hydrolase) | 11707 | -0.673 | -0.0011 | No |
| 154 | ABCA1 | NA | ABCA1 Entrez,  Source | ATP-binding cassette, sub-family A (ABC1), member 1 | 11871 | -0.716 | -0.0097 | No |
| 155 | SLC16A6 | NA | SLC16A6 Entrez,  Source | solute carrier family 16, member 6 (monocarboxylic acid transporter 7) | 11937 | -0.735 | -0.0109 | No |
| 156 | SIK1 | NA | 12035 | -0.767 | -0.0144 | No | ||
| 157 | SLC2A6 | NA | SLC2A6 Entrez,  Source | solute carrier family 2 (facilitated glucose transporter), member 6 | 12151 | -0.805 | -0.0190 | No |
| 158 | CD80 | NA | CD80 Entrez,  Source | CD80 molecule | 12189 | -0.816 | -0.0179 | No |
| 159 | PLAU | NA | PLAU Entrez,  Source | plasminogen activator, urokinase | 12310 | -0.855 | -0.0226 | No |
| 160 | GEM | NA | GEM Entrez,  Source | GTP binding protein overexpressed in skeletal muscle | 12453 | -0.919 | -0.0287 | No |
| 161 | IRS2 | NA | IRS2 Entrez,  Source | insulin receptor substrate 2 | 12470 | -0.925 | -0.0255 | No |
| 162 | PMEPA1 | NA | 12482 | -0.930 | -0.0219 | No | ||
| 163 | SGK1 | NA | 12552 | -0.961 | -0.0224 | No | ||
| 164 | RHOB | NA | RHOB Entrez,  Source | ras homolog gene family, member B | 13181 | -1.375 | -0.0619 | No |
| 165 | NR4A2 | NA | NR4A2 Entrez,  Source | nuclear receptor subfamily 4, group A, member 2 | 13281 | -1.489 | -0.0621 | No |
| 166 | NR4A3 | NA | NR4A3 Entrez,  Source | nuclear receptor subfamily 4, group A, member 3 | 13295 | -1.507 | -0.0559 | No |
| 167 | SLC2A3 | NA | SLC2A3 Entrez,  Source | solute carrier family 2 (facilitated glucose transporter), member 3 | 13297 | -1.509 | -0.0488 | No |
| 168 | KLF9 | NA | KLF9 Entrez,  Source | Kruppel-like factor 9 | 13300 | -1.512 | -0.0418 | No |
| 169 | NFIL3 | NA | NFIL3 Entrez,  Source | nuclear factor, interleukin 3 regulated | 13322 | -1.542 | -0.0361 | No |
| 170 | ZBTB10 | NA | ZBTB10 Entrez,  Source | zinc finger and BTB domain containing 10 | 13360 | -1.592 | -0.0313 | No |
| 171 | DUSP2 | NA | DUSP2 Entrez,  Source | dual specificity phosphatase 2 | 13368 | -1.602 | -0.0242 | No |
| 172 | PNRC1 | NA | PNRC1 Entrez,  Source | proline-rich nuclear receptor coactivator 1 | 13437 | -1.721 | -0.0211 | No |
| 173 | BMP2 | NA | BMP2 Entrez,  Source | bone morphogenetic protein 2 | 13439 | -1.723 | -0.0130 | No |
| 174 | FOS | NA | FOS Entrez,  Source | v-fos FBJ murine osteosarcoma viral oncogene homolog | 13543 | -1.911 | -0.0115 | No |
| 175 | CD83 | NA | CD83 Entrez,  Source | CD83 molecule | 13621 | -2.139 | -0.0070 | No |
| 176 | BTG2 | NA | BTG2 Entrez,  Source | BTG family, member 2 | 13659 | -2.285 | 0.0011 | No |
| 177 | ID2 | NA | ID2 Entrez,  Source | inhibitor of DNA binding 2, dominant negative helix-loop-helix protein | 13694 | -2.466 | 0.0103 | No |

